List Title | APhA DrugInfoLine

Focus on Asthma Care

SORT BY: Most Recent Most Viewed

August 28, 2012

Breathe easy: New analysis fails to link leukotriene modifiers with suicide

READ

PREVIEW
Use of leukotriene-modifying agents (LTMAs) was not associated with an increased risk of suicide attempt over a 10-year period in patients between 5 and 24 years of age with asthma, according to...
May 8, 2012

New data shed light on safety of long-acting beta-2 agonist combos in asthma

READ

PREVIEW
The combination of an inhaled corticosteroid (ICS) and a long-acting beta-2 agonist (LABA) protects against severe asthma exacerbations as well or better than an ICS alone in a diverse...
December 17, 2011

Better understanding of asthma could lead to primary prevention

READ

PREVIEW
Could we one day prevent asthma before it occurs? That possibility is within sight, according to a recently published review of the natural history of the age-old disease.
September 20, 2011

Nitric oxide levels: New measure for guiding treatment of airway disease

READ

PREVIEW
The American Thoracic Society (ATS) has released the first-ever recommendations for use of fractionated exhaled nitric oxide (FE_NO) to aid in diagnosis of and clinical decisions about...
September 13, 2011

Lebrikizumab provides insights into interleukin-13 role in asthma

READ

PREVIEW
Treatment with the experimental drug lebrikizumab, a humanized monoclonal antibody to interleukin-13, increased lung function in adults with asthma. Drug effects in the Phase II trial were...

Pages

Medication Monitor

RSS Follow Medication Monitor on Twitter Follow APhA Druginfoline on Twitter

2215 Constitution Avenue NW, Washington, DC 20037 Telephone 202-628-4410 Fax 202-783-2351

© 2013 American Pharmacists Association All Rights Reserved.

About the American
Pharmacists Association

The American Pharmacists Association (APhA) is the organization whose members are recognized in society as essential in all patient care settings for optimal medication use that improves health, wellness and quality of life. Through information, education and advocacy, APhA empowers its members to improve medication use and advance patient care.

About APhA DrugInfoLine

APhA DrugInfoLine (ISSN 2162-3015) is a weekly publication of, and is owned and copyrighted by the American Pharmacists Association, the national professional society of pharmacists. Materials in APhA DrugInfoLine do not neccessarily represent the policy, recommendations, or endorsement of APhA. The publisher, authors, editors, reviewers, and contributors have taken care to ensure that the information contained in APhA DrugInfoLine is accurate and current; however, they shall have no ability to any person or entity with regard to claims, losses, or damage caused or alleged to be caused, directly or indirectly by use of any information contained in the publication. All decisions about drug therapy must be based on independent judgement of the clinician.